We evaluate the clinical validity of the pharmacogenomic test combination and the implementation guidelines for single clinical pharmacogenetics (CPIC) on patient outcomes and blood levels […]
Continue readingCategory: Elisa Kits
Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
One target drug for plaque psoriasis treatment is apremilast, which is a phosphodiesterase 4 (PDE4) inhibitor selective. In this study, 34 patients with moderate and […]
Continue reading